Embla Medical hf.
OSSFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,727,908 | $1,702,203 | $1,516,462 | $2,735,603 |
| - Cash | $86,163 | $72,653 | $76,631 | $85,197 |
| + Debt | $499,789 | $467,733 | $480,922 | $448,151 |
| Enterprise Value | $2,141,534 | $2,097,283 | $1,920,753 | $3,098,557 |
| Revenue | $854,889 | $785,683 | $718,650 | $718,669 |
| % Growth | 8.8% | 9.3% | -0% | – |
| Gross Profit | $500,247 | $454,392 | $407,942 | $421,070 |
| % Margin | 58.5% | 57.8% | 56.8% | 58.6% |
| EBITDA | $167,942 | $143,249 | $118,127 | $150,546 |
| % Margin | 19.6% | 18.2% | 16.4% | 20.9% |
| Net Income | $68,278 | $58,389 | $42,513 | $63,994 |
| % Margin | 8% | 7.4% | 5.9% | 8.9% |
| EPS Diluted | 0.16 | 0.14 | 0.1 | 0.15 |
| % Growth | 14.3% | 40% | -33.3% | – |
| Operating Cash Flow | $116,066 | $94,324 | $60,771 | $100,530 |
| Capital Expenditures | -$39,227 | -$42,278 | -$25,942 | -$26,688 |
| Free Cash Flow | $76,839 | $52,046 | $34,829 | $73,842 |